CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.210
+0.170 (8.34%)
At close: Nov 20, 2024, 4:00 PM
2.090
-0.120 (-5.44%)
After-hours: Nov 20, 2024, 7:04 PM EST
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $25.51 million as of November 21, 2024. Its market cap has decreased by -36.97% in one year.
Market Cap
25.51M
Enterprise Value
20.79M
1-Year Change
-36.97%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $25.51M, a decrease of -44.69%. That is a compound annual growth rate of -30.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 25.51M | -54.85% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MIRA Pharmaceuticals | 22.94M |
| Lisata Therapeutics | 22.63M |
| Tempest Therapeutics | 22.53M |
| Enlivex Therapeutics | 22.48M |
| XTL Biopharmaceuticals | 22.48M |
| Kairos Pharma | 21.96M |
| Bionano Genomics | 21.86M |
| NeurAxis | 21.64M |